Sichuan Biokin Pharmaceutical Co.,Ltd. (SHA:688506)
China
· Delayed Price · Currency is CNY 283.50
-8.01 (-2.75%)
At close: Apr 23, 2025, 2:57 PM CST
SHA:688506 Revenue
In the year 2024, Sichuan Biokin Pharmaceutical had annual revenue of 5.82B CNY with 936.31% growth. Sichuan Biokin Pharmaceutical had revenue of 160.16M in the quarter ending December 31, 2024, a decrease of -13.04%.
Revenue
5.82B
Revenue Growth
+936.31%
P/S Ratio
19.52
Revenue / Employee
2.79M
Employees
2,086
Market Cap
113.68B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 5.82B | 5.26B | 936.31% |
| Dec 31, 2023 | 561.87M | -141.41M | -20.11% |
| Dec 31, 2022 | 703.28M | -93.45M | -11.73% |
| Dec 31, 2021 | 796.73M | -215.98M | -21.33% |
| Dec 31, 2020 | 1.01B | -193.91M | -16.07% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2014 | Pro | Pro | Pro |
| Dec 31, 2013 | Pro | Pro | Pro |
| Dec 31, 2012 | Pro | Pro | Pro |
| Dec 31, 2011 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jiangsu Hengrui Medicine | 27.98B |
| Shenzhen Mindray Bio-Medical Electronics | 37.11B |
| WuXi AppTec | 37.92B |
| Zhangzhou Pientzehuang Pharmaceutical., | 10.91B |
| Aier Eye Hospital Group | 20.62B |
| Shanghai United Imaging Healthcare | 10.30B |
| Yunnan Baiyao Group Co.,Ltd | 40.03B |
| Beijing Wantai Biological Pharmacy Enterprise | 2.25B |